Here is the English translation of the Chinese title: **Kaneka Ubiquinol™ Wins Prestigious Vitafoods Europe Innovation Award 2026 in Collaboration with Eqology**

Kaneka Ubiquinol™’s innovative collaboration philosophy centered on “formulation flexibility” drives world-class award-winning results

With growing consumer demand for cellular health solutions, mitochondrial health technology powered by reduced coenzyme Q10 has taken a central role in global food, nutraceutical, and beverage formulations.

Barcelona, SpainMay 12, 2026 /PRNewswire/ — Kaneka Ubiquinol™, the world’s sole innovative manufacturer and pioneer in reduced coenzyme Q10, and the first sponsor of the Mitochondrial Health category at Vitafoods Europe 2026, today announced that its collaboration with Eqology Pure Arctic Oil Heart & Energy has won the Most Innovative Ready-to-Eat Nutraceutical Finished Product award at the 2026 Vitafoods Europe Innovation Awards.

This groundbreaking, category-defining formulation, Eqology Pure Arctic Oil Heart & Energy, combines sustainably sourced CodMarine® Arctic cod liver oil, organic cold-pressed extra virgin olive oil, vitamin D3, and Kaneka Ubiquinol™ ingredients.

The formulation has a solid scientific foundation, proven to support cardiovascular health and cellular energy health, with verified oxidative stability^[i]. Its dual use as both a dietary supplement and a cooking oil fully demonstrates the high flexibility of the formulation, easily integrating into daily health regimens—blending pure marine-sourced nutrients, Mediterranean phytonutrients, and mitochondrial science into a clinically credible, sustainable, and innovative nutritional solution; while also serving as a uniquely flavorful nutritional or seasoning oil to help people adopt a healthy lifestyle diet.

At the heart of this groundbreaking innovation is Kaneka Ubiquinol™—the highly bioactive form of coenzyme Q10, which plays a crucial role in mitochondrial energy production and antioxidant protection.

Mitochondria are responsible for generating approximately 90% of the body’s energy^[ii], and natural levels of reduced coenzyme Q10 in the human body begin to decline from the age of 20^[iii]. Therefore, supporting mitochondrial energy production has been increasingly validated by research as significant for cardiovascular health, reproductive health, women’s health, cognitive function, and healthy aging.

On the occasion of this honor, Filip Van Hulle, General Manager of Kaneka Europe, stated: “This significant achievement reinforces our commitment to further driving innovation—we will collaborate with brands that possess world-class scientific strength and expertise to jointly create high-quality products that deliver genuine innovative value in the field of mitochondrial health.”

About KANEKA Ubiquinol™

Kaneka Corporation is the award-winning, world’s sole innovative manufacturer, producing clinically verified bioequivalent ubiquinol reduced coenzyme Q10 through an award-winning Japanese natural fermentation process. Kaneka Ubiquinol™ has over 100 studies, more than 80 patents, and over 45 years of research accumulation in areas such as cardiovascular health, cognitive function, women’s health, reproductive health, and energy support. Since 2006, Kaneka Ubiquinol™ has been used by over 1,000 nutritional health brands in more than 50 countries and regions worldwide, and has obtained multiple international certifications, including HALAL, GRAS, HACCP, NDI, KOSHER, GMP, ISO 14001, ISO 22000, Non-GMO, and OSHMS.

Website: www.kaneka-ubiquinol.com